Table 4.

Vascular, cardiac, and pulmonary function in survivors and controls at the time of neurocognitive testing

TestSurvivorsControlsP value∗
Mean (SD)Mean (SD)
Pulmonary function test    
FEV1 (% predicted) 82.69 (15.95) 96.23 (13.31) <.001 
FEV1/FVC (%) 0.99 (0.09) 1.00 (0.08) .240 
TLC (% predicted) 87.27 (15.33) 98.97 (12.89) <.001 
DLCOcor (% predicted) 83.31 (16.70) 98.03 (14.93) <.001 
Cardiac function test    
Ejection fraction (3D ECHO) (%) 0.56 (0.06) 0.60 (0.05) <.001 
GLS (%) −18.30 (2.88) −20.37 (2.24) <.001 
Vascular studies    
Pulse wave velocity (m/s) 6.89 (1.70) 7.24 (4.04) .300 
Large artery elasticity (mL/mm Hg) 17.44 (6.03) 18.23 (5.01) .060 
SAE (mL/mm Hg) 6.94 (3.39) 8.25 (3.43) <.001 
Systolic blood pressure (mm Hg) 124.75 (15.94) 126.02 (12.51) .410 
Diastolic blood pressure (mm Hg) 74.34 (10.55) 76.23 (9.87) .078 
TestSurvivorsControlsP value∗
Mean (SD)Mean (SD)
Pulmonary function test    
FEV1 (% predicted) 82.69 (15.95) 96.23 (13.31) <.001 
FEV1/FVC (%) 0.99 (0.09) 1.00 (0.08) .240 
TLC (% predicted) 87.27 (15.33) 98.97 (12.89) <.001 
DLCOcor (% predicted) 83.31 (16.70) 98.03 (14.93) <.001 
Cardiac function test    
Ejection fraction (3D ECHO) (%) 0.56 (0.06) 0.60 (0.05) <.001 
GLS (%) −18.30 (2.88) −20.37 (2.24) <.001 
Vascular studies    
Pulse wave velocity (m/s) 6.89 (1.70) 7.24 (4.04) .300 
Large artery elasticity (mL/mm Hg) 17.44 (6.03) 18.23 (5.01) .060 
SAE (mL/mm Hg) 6.94 (3.39) 8.25 (3.43) <.001 
Systolic blood pressure (mm Hg) 124.75 (15.94) 126.02 (12.51) .410 
Diastolic blood pressure (mm Hg) 74.34 (10.55) 76.23 (9.87) .078 

P value from a linear regression model adjusted for age and sex.

DLCOcor, diffusion capacity of the lungs for carbon monoxide corrected for hemoglobin; FVC, forced vital capacity; TLC, total lung capacity.

Close Modal

or Create an Account

Close Modal
Close Modal